The 2023 Annual General Meeting of Shareholders of Japan VietNam Medical Investment  and Development Joint Stock Company (JVC) was successfully held at the 8th-floor hall, VNCC building, 243 De La Thanh, Ward Lang Thuong, Dong Da District, Hanoi on the morning of May 19, 2023.

The Presidium at the General Meeting includes the following members:

• Ms: Nguyen Thi Hanh – Chairman of the Board of Directors (Chairman of the meeting)
• Mr: Pham Thanh Nam – Vice Chairman of the Board of Directors / General Director (Member of the Presidium)
• Mr: Nguyen Thi Phuong – Member of the Board of Directors (Member of the Presidium)

The General Meeting voted and approved the following contents:

• Approving the report of the Board of Directors and the Board of Directors of JVC on activities in 2022 and the business plan in 2023.
• Approving the report on activities of the Supervisory Board in 2022.
• Approving the audited financial statements of the Company in 2022.
• Approving the Company's 2022 profit distribution plan.
• Approving the payment of remuneration of the Board of Directors and Supervisory Board in 2022 and the plan of total remuneration in 2023.
• Approving the list of auditors of the Company's 2023 financial statements.
• Approving the resignation of a member of the Board of Directors.
• Approving the election of additional members of the Board of Directors of the Company for the term 2021 - 2026.

2022 is the financial year that JVC has only 9 months of operation (from April 1, 2022, to December 31, 2022), this is also the first year JVC implemented OKRs - a new management method and transparent internal training culture. With the guideline throughout the year: "Transformation - Speed ​​- Breakthrough", the Company has taken advantage of market opportunities and implemented synchronous solutions to increase revenue, control, and save costs in administration and operation. 

Although facing many difficulties due to the medical equipment market is a market with very fierce competition; subject to much control of mechanisms, policies, disbursement speed, and strict bidding regulations; Under the leadership of the Board of Directors and the efforts and perseverance of the Board of Directors and all employees, 2022 JVC has achieved some sales results as follows:

• Net revenue: 396.3 billion dong, reaching ~99% of the plan of the AGM 2022;
• Profit after tax: 21.7 billion VND

2022 is also the year that JVC continues to focus on traditional products such as Consumables, diagnostic imaging equipment, affiliate business activities, technical services, health check-ups, etc. In addition, the Company added to the list of goods other items such as DR plates, catheters, infusion lines, and invasive arterial blood pressure monitors, and at the same time focused on increasing the operational efficiency of the Diagnostic Imaging Center.

After a difficult period due to the impact of the Covid-19 epidemic, with the principle of respecting the law and putting the people’s interest first, JVC promoted its sustainable development strategy to regain the No. in the industry. Thanks to the great efforts of the Board of Directors and employees, JVC has completed several important tasks such as:

• Continuing to promote strengths in traditional product lines and business activities
• Profit after tax is 21.7 billion VND, reaching 86.8% of the plan
• Recovering 2 billion old and bad debts
• Invested 6.9 billion to purchase fixed assets to serve business activities
• Revenue from financial activities reached VND 13.1 billion

Strategic orientation 2023 – 2027:

• JVC's Board of Directors set the goal of breakthrough revenue growth, sustainable profit over the years, diversifying more products, and promoting advantages with traditional products.
• To become a reliable partner providing diversified and comprehensive equipment, materials, solutions, and services for medical units; put legal safety and service quality on top.
• Excellent operation management: Building a lean and efficient apparatus; perfecting regulations and processes towards automation, resource planning, and management.
• Training and developing elite and enthusiastic force: Strengthening training of professional capacity and skills; taking care to ensure stability and improve the lives of employees; Company culture building.
• Completely handle financial, debt, and legal issues.

At the General Meeting, shareholders also approved the election of Mr. Nguyen Hai Ha to hold the position of member of the Board of Directors of the Company for the term 2021 - 2026.

*****

Japan Vietnam Medical Development and Investment Joint Stock Company (JVC), established in 2001, has a long history in the medical equipment distribution field, medical consumables, joint investment, technical services, IT services, and polyclinics.

Over the years, JVC has focused on providing mobile medical examination services for domestic and foreign companies in 64 provinces and cities. JVC owns the largest number of digital X-ray mobile examination vehicles in Vietnam, including 20 medical examination vehicles with 3 systems: mobile medical examination vehicle, mobile CT Scanner, and mobile Mammo examination vehicle.